Replimune Group (($REPL)) announced an update on their ongoing clinical study. Replimune Group is conducting a Phase 1B/2 study titled ‘An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback